In addition to previously reported survival benefits, the taxane cabazitaxel improved quality of life in patients with advanced metastatic prostate cancer compared to the androgen signalling targeted inhibitors abiraterone and enzalutamide, reports the latest analysis [more]
An observational cohort study just published on the peer-reviewed journal Cancer concluded that the costs of breast cancer chemotherapy vary widely in the United States, even among treatment regimens with similar efficacy, and that patients [more]
Standards of care are not yet defined for patients with recurrent glioblastoma. In this critical review, Katharina Seystahl and colleagues summarise the available literature for patients with recurrent (progressive) glioblastoma treated with repeat surgery, re-irradiation, [more]
The WIN 2016 Symposium program will elaborate the overarching theme Innovative Approaches to Improve Cancer Patient Outcomes in four plenary sessions, divided over the two days of the meeting: New tools for early diagnosis, selecting therapies and monitoring [more]